Embryonal Rhabdomyosarcoma: A Case Report on A 2 Months-Old Infant
Main Article Content
Abstract
Rhabdomyosarcoma (RMS) is an aggressive malignant neoplasma of the musculoskeletal system that represents 50% of all soft tissue sarcoma in children. Rhabdomyosarcoma is the most common soft tissue sarcoma in children, while the majority of rhabdomyosarcoma cases occurs in children under the age of 6 years old, RMS is uncommon in infants. Since there is no clear evidence that the biology of RMS itself is different in infants, the reason for a poorer prognosis is unclear. This case report aims to further examine the pathological features, diagnosis and treatment for embryonal rhabdomyosarcoma. We present a case of a 2 months-old infant with post biopsy inci- sion 12 days prior to hospital admission which is then reffered to the oncologist for further obser- vation. An anatomy pathological examination was done, observed from a 2 x 0,5 x 0,5 brown firm sample which was then revealed as embryonal rhabdomyosarcoma.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Anderson, Hawkins, D. S., Carola, A. S. & Arndt, 2011. Rhabdomyosarcoma in infants less than one year of age: a report from the children’s oncology group.. Cancer, 15(117), pp. 3493 3501.Tavel, P. 2007 Modeling and Simulation Design. AK Peters Ltd.
II. Andrade, CR, T. J. A. N. I. K. L. L. M., 2010. Rhabdomyosarcoma of the head and neck: a clinicopathological and immunohistochemical analysis of 29 cases.. Brazilian dental journal, 1(21), pp. 68-73.Brown, L. D., Hua, H., and Gao, C. 2003. A widget framework for augmented interaction in SCAPE.
III. Cecchetto G, G. M. I. A. Z. I. D. P. G. C. C. M., 2001. Primary re-excision: the Italian experience in patients with localized soft-tissue sarcomas.. Pediatr Surg Int, Volume 17, pp. 532-534.
IV. Chen, X. et al., 2013. Children’s research Hospital–Washington University Pediatric Cancer Genome, targeting oxidative stress in embryonal rhabdomyosarcoma.. Cancer Cell, Volume 24, p. 710–24.
V. Dall’Igna P, D. C. F. A. R. C. G., 2104. Sentinel node biopsy in pediatric patients: the experience in a single institution.. Eur J Pediatr Surg, Volume 24, pp. 482-487 .
VI. Eaton BR, M. M. K. S. M. R. J. S. A. C. Z. e. a., 2013. Radiation therapy target volume reduction in pediatric rhabdomyosarcoma.. Cancer, Issue 119, p. 1578–85.
VII. Gallego M S, S. d. T. C. J., 2005. Rhabdomyosarcoma: present and future perspectives in diagnosis and treatment. . Clin Transl Oncol, 1(7), pp. 35-41.
VIII. Koscielniak , E. et al., 1999. Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS 86. J Clin Oncal, Volume 17, pp. 3706-19.
IX. Malempati, S. et al., 2011. Rhabdomyosarcoma of the oral cavity: a case report.. European journal of Dentistry., 3(5), p. 340.
X. Maurer, H. M. et al., 1993. The intergroup rhabdomyosarcoma study-II.. Cancer, Volume 71, p.1904–22.
XI. Ognjanovic S, C. S. C. E. F. E. H. S. M. C. M. B. P. S. R. P. V. B. J. S. L., 2010. Birth
XII. characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype. Br J Cancer. , 1(102), pp. 227-31.
XIII. Parham, D. M. & Barr, F. G., 2013. Classification of rhabdomyosarcoma and its molecular basis. Adv Anat Pathol, 6(20), pp. 387-97.